India has always been in the eye of the storm when it comes to the country's mounting spurious medicine problem. Even the US Trade Representative (USTR) has scrutinized Indian pharmaceutical companies over this issue since according to its report, approximately 20 percent of all drugs on sale in our market are counterfeit. And this is the kind of study that can adversely affect India's budding market and reputation, even as it ranks third in the world in terms of volume. India fulfills over 20 percent of the global demand for generic drugs, which is no surprise because we have over 10,500 manufacturing units and 3,000 firms across the country.
But the fact remains that if the industry does not invest correctly in the short term, India may fall behind in the race due to a sheer lack of quality products. To regain our status in the world pharma rankings, the Indian industry will have to take certain measures such as encouraging innovation through augmented spending on R&D, making marketing companies also accountable for product quality, and implementing more stringent quality control (QC).
Following are some more factors implementing which can directly result in improving the quality of Indian drugs and ensuring they are of the best quality going forward:
API quality check
Diese Geschichte stammt aus der September 2022-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der September 2022-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Are You Sleeping Enough, Doctor?
In this engaging conversation, we delve into the world of sleep with Dr Prashant Makhija, Consultant Neurologist, Wockhardt Hospital, Mumbai Central. Dr Prashant sheds light on the often overlooked aspect of healthcare–the sleep health of doctors. With a compassionate understanding of the challenges faced by the Indian doctors, he advocates for sleep equity, ensuring that our healthcare heroes are at their best for themselves and their patients.
Will India Eradicate Malaria By 2027?
India's ambitious malaria eradication goal faces a few hurdles despite progress made and the industry efforts.
Medikabazaar opens CDC in Kolkata
Medikabazaar, a B2B online healthcare platform, has inaugurated a new Central Distribution Center CDC) in Kolkata.
Alcon unveils Clareon IOLs in India
Global eye care player Alcon launches Clareon family of intraocular lenses IOLs) in India.
USV opens plant in Himachal Pradesh
To manufacture cardiology targeted medicine products at the new plant.
A RAY OF HOPE FOR HEART PATIENTS
Faced with severe heart failure, an 84-year-old gets a fresh lease of life due to Impella, a tiny device. Learn how Impella is changing patient lives in India.
R+CU'S CANCER TREATMENT PROMISE: HOPE OR HYPE?
Tata Memorial Center’s proposed cancer pill claims to tackle recurrence, but human trials are needed for confirmation, says the author.
BRIDGING THE KIDNEY TRANSPLANTS GAP
Explore the current landscape, including breakthroughs, access barriers, and promising future directions for kidney transplantation in modern India.
Wockhardt runs women empowerment campaign
Wockhardt Hospitals concludes International Women’s Day 2024 celebrations with “I am Fearless” campaign promoting women empowerment.
Feminine hygiene and cervical cancer awareness drive unveiled
CARE Hospitals launches Tejaswini, a CSR initiative focusing on feminine hygiene and cervical cancer awareness for girls in Hyderabad